Physicists reach atomic-scale telegraphy with light phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.
Medigene AG: Medigene achieves positive preliminary results in Phase I of Phase I/II trial of TCR-T therapy MDG1011 in blood cancers Planegg/Martinsried (pta/21.12.2021/15:20) MDG1011 was safe and well tolerated Successful individual manufacturing of MDG1011 drug product from heavily pre-treated patients wi.
/PRNewswire/ In its effort to develop effective cellular immunotherapies for cancer treatment, the Regensburg Center for Interventional Immunology (RCI) in.
Regensburg Center for Interventional Immunology adopts
LUMICKS’ z-Movi® Cell Avidity Analyzer
Amsterdam, the Netherlands – May 27, 2021 – In its effort to develop effective cellular immunotherapies for cancer treatment, the Regensburg Center for Interventional Immunology (RCI) in Germany has purchased LUMICKS’ z-Movi® Cell Avidity Analyzer. The placement highlights the promise of measuring cell avidity between immune cells and their tumor targets to improve the selection of chimeric antigen receptors (CARs) and accelerate the development of new CAR-T therapies.
The new instrument has been placed in the lab of Dr. Hinrich Abken, Professor and Chair for Genetic Immunotherapy at Regensburg University. Professor Abken is a pioneer in the design and development of CAR T cells for cancer malignancies. His current work is aimed at improving T cell targeting of cancer cells and at translating these strategies into clinical trials.
A team of physicists from Germany, the US and the UK managed to observe the motion of electrons from one atomically thin layer into an adjacent one with nanoscale spatial resolution. The new conta .